No connection

Search Results

QTI

BEARISH
$6.93 Live
QT Imaging Holdings, Inc. · NASDAQ
Target $11.6 (+67.4%)
$4.9 52W Range $46.05

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 18, 2026
Market cap
$83.45M
P/E
N/A
ROE
N/A
Profit margin
-111.4%
Debt/Equity
0.81
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
90%
The company exhibits critical financial weakness with a Piotroski F-Score of 1/9, indicating severe fundamental distress. Despite an extraordinary YoY revenue growth of 877.20%, the company remains deeply unprofitable with a profit margin of -111.40% and a history of massive earnings misses. Technical trends are overwhelmingly bearish, characterized by a 78.7% price collapse over the last six months. While short-term liquidity is stable, the combination of poor health scores and negative earnings progression suggests a high risk of further devaluation.

Key Strengths

Explosive YoY revenue growth of 877.20%
Strong gross margin of 45.36% indicating product value
Healthy short-term liquidity with a Current Ratio of 2.81
Manageable Debt/Equity ratio of 0.81
Analyst target price ($11.60) suggests significant potential upside if turnaround occurs

Key Risks

Critical fundamental health as evidenced by Piotroski F-Score of 1/9
Severe net losses with a profit margin of -111.40%
Catastrophic price performance (-95.3% over 5 years)
Poor earnings track record with an average surprise of -2293.48%
Extremely high Price-to-Book ratio (12.79) for a non-profitable entity

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
20
Weak
Value
15
Future
65
Past
10
Health
11
Dividend
0
AI Verdict
High-Risk Speculative
Key drivers: Extreme revenue growth, Critical Piotroski F-Score, Severe price depreciation, Deep negative profit margins
Confidence
85%
Value
15/100

Ref P/B 12.79, P/S 4.41

Positives
No standout positives identified.
Watchpoints
  • P/B ratio of 12.79 is excessive
  • No Graham Number available due to lack of earnings
Future
65/100

Ref Revenue Growth (YoY)

Positives
  • Hyper-growth in revenue (877%)
Watchpoints
  • Inability to translate growth into profit
Past
10/100

Ref Historical Price Performance

Positives
No standout positives identified.
Watchpoints
  • 5Y Change of -95.3%
  • 6M Change of -78.7%
Health
11/100

Ref Piotroski F-Score

Positives
  • Current Ratio 2.81
Watchpoints
  • Piotroski F-Score 1/9
  • ROA -19.05%
Dividend
0/100

Ref Dividend Yield N/A

Positives
No standout positives identified.
Watchpoints
  • No dividend paid

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$6.93
Analyst Target
$11.6
Upside/Downside
+67.4%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for QTI and closest competitors.

Updated 2026-04-17
QTI
QT Imaging Holdings, Inc.
Primary
5Y
-95.3%
3Y
-95.6%
1Y
-34.0%
6M
-78.7%
1M
+0.9%
1W
+0.3%
PAR
Park Dental Partners, Inc.
Peer
5Y
+75.8%
3Y
+75.8%
1Y
+75.8%
6M
+75.8%
1M
+5.4%
1W
+1.2%
OKY
OKYO Pharma Limited
Peer
5Y
-54.4%
3Y
+32.0%
1Y
+47.3%
6M
-20.3%
1M
-1.8%
1W
+3.8%
AMW
American Well Corporation
Peer
5Y
-99.3%
3Y
-93.4%
1Y
-55.6%
6M
-45.6%
1M
+6.1%
1W
+3.4%
GOS
Gossamer Bio, Inc.
Peer
5Y
-95.6%
3Y
-66.2%
1Y
-57.8%
6M
-85.5%
1M
-26.7%
1W
+0.4%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
12.79
P/S Ratio
4.41
EV/Revenue
4.14
EV/EBITDA
-18.18
Market Cap
$83.45M

Profitability

Profit margins and return metrics

Profit Margin -111.4%
Operating Margin -8.46%
Gross Margin 45.36%
ROE N/A
ROA -19.05%

Growth

Revenue and earnings growth rates

Revenue Growth +877.2%
Earnings Growth N/A
Q/Q Revenue Growth +877.57%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.81
Moderate
Current Ratio
2.81
Strong
Quick Ratio
2.07
Excellent
Cash/Share
$0.86

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
38.0%
Op. Margin
-8.5%
Net Margin
-16.8%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
2.57x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
102%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-15
$N/A
2026-02-18
$-0.1
+13.0% surprise
2025-11-10
$-0.47
-4600.0% surprise
2025-08-07
$-0.42

Healthcare Sector Comparison

Comparing QTI against 421 companies in the Healthcare sector (25 bullish, 134 neutral, 262 bearish)
Profit Margin
-111.4%
This Stock
vs
-13.63%
Sector Avg
+717.4% (Superior)
Debt to Equity
0.81
This Stock
vs
3.22
Sector Avg
-74.7% (Less Debt)
Revenue Growth
877.2%
This Stock
vs
121.05%
Sector Avg
+624.6% (Fast Growth)
Current Ratio
2.81
This Stock
vs
4.55
Sector Avg
-38.3% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

KLOCK JOHN C JR.
Director and Beneficial Owner of more than 10% of a Class of Security
Stock Award
2026-03-20
3,500 shares
GREENE JAMES S
Director
Stock Award
2026-03-20
3,500 shares
KATZ AVISHAY S.
Chairman of the Board
Stock Award
2026-03-20
3,500 shares
JENNINGS JAY WALTER
Chief Financial Officer
Stock Award
2026-03-20
2,800 shares
DINU RALUCA
Chief Executive Officer
Stock Award
2026-03-20
519,500 shares
TAYLOR ROSS
Director
Stock Award
2026-03-20
3,500 shares
DICKSON DANIEL H
Director
Stock Award
2026-03-20
3,500 shares
WEINER ZEEV
Director
Stock Award
2026-03-20
3,500 shares
WEINER ZEEV
Director
Option Exercise
2026-03-17
23,054 shares · $48,217
KATZ AVISHAY S.
Chairman of the Board
Buy
2026-01-22
24,107 shares · $155,008
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-03-25

Qualcomm Inc. (QTI) likely reported its quarterly financial results.

8-K
8-K
2026-03-25

Qualcomm Inc. (QTI) likely reported its quarterly financial results.

10-K
10-K
2026-03-25

QTI filed its annual 10-K report on March 25, 2026. Due to the absence of provided excerpts, specific financial highlights and risk factors are unavailable for summary.

8-K
8-K
2026-02-25

Qualcomm Inc. filed an 8-K on February 25, 2026, likely to announce its quarterly financial results.

8-K
8-K
2026-02-18

Qualcomm Inc. filed an 8-K on February 18, 2026, likely to announce its quarterly financial results.

8-K
8-K
2026-02-06

Qualcomm Inc. announced its quarterly financial results in an 8-K filing on February 6, 2026.

8-K
8-K
2026-01-27

Qualcomm Inc. (QTI) filed an 8-K on January 27, 2026, likely to announce its quarterly financial results.

8-K
8-K
2026-01-23

Qualcomm Inc. announced its quarterly financial results in an 8-K filing on January 23, 2026.

8-K
8-K
2026-01-20

Qualcomm Inc. (QTI) filed an 8-K on January 20, 2026, likely to announce its quarterly financial results.

S-1/A
S-1
2025-12-29

QTI filed an amended registration statement (Form S-1/A) on December 29, 2025, in connection with its proposed initial public offering.

8-K
8-K
2025-12-23
8-K
8-K
2025-12-11
10-Q
10-Q
2025-11-12
8-K
8-K
2025-11-10
8-K
8-K
2025-11-10
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning QTI from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile